An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima · 2024
Read An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction by Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11551477.txt.
Description
Ryutaro Iwama and three co-authors check the dosing of febuxostat, a drug for high uric acid and gout, in children. They pooled blood-level data from 29 Japanese child patients and 113 adults, some healthy and some with kidney problems, in one shared model. The model described drug handling in both age groups with a single structure. Body weight and kidney function shaped how fast the drug cleared, and eating changed how much of it entered the blood.
Simulated steady levels in fed children weighing 20 to 40 kilos matched adult levels when the children took half the adult dose at each step. Children at or above 40 kilos matched adults on the full dose. Weight-adjusted clearance barely differed between children and adults with the same kidney status. The authors support the half-dose rule under 40 kilos, with no cut for mild or moderate kidney problems.
Catalog record
| CREATOR | Ryutaro Iwama, Kimie Nishida, Daisuke Ishii, Takeshi Iijima |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |